A high-throughput platform identifies novel drug combinations towards acute myeloid leukemia therapy

被引：0
|
作者：
Soltis, Anthony R.
Zhelyazkova, Boryana
Drane, Pascal
Eleftheriadis, Efstathios
Ventresco, Andrew
Weitz, David A.
Lee, Arlinda
Iafrate, Anthony J.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3900
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A3900
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A novel high-throughput screen of primary leukemia cells to personalize therapy for relapsed/refractory acute myeloid leukemia (AML): Proof of concept and clinical implementation of precision medicine
    Shum, David
    Santos, Ruth
    Heaney, Mark
    Brentjens, Renier
    Maslak, Peter
    Rosenblat, Todd
    Jurcic, Joseph
    Djaballah, Hakim
    Frattini, Mark G.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [42] Optimization of a Drug Screening Platform in Acute Myeloid Leukemia
    Chat, Laureen
    Pasanisi, Justine
    Pacchiardi, Kim
    Pioton, Alya
    Duchmann, Matthieu
    Itzykson, Raphael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S232 - S232
  • [43] High-throughput kinase profiling as a platform for drug discovery
    David M. Goldstein
    Nathanael S. Gray
    Patrick P. Zarrinkar
    Nature Reviews Drug Discovery, 2008, 7 : 391 - 397
  • [44] High-Throughput Purification Platform in Support of Drug Discovery
    Liu, Min
    Chen, Kuanchang
    Christian, Denny
    Fatima, Tazeen
    Pissamitski, Natalya
    Streckfuss, Eric
    Zhang, Chaowei
    Xia, Lei
    Borges, Scott
    Shi, Zhicai
    Vachal, Petr
    Tata, James
    Athanasopoulos, John
    ACS COMBINATORIAL SCIENCE, 2012, 14 (01) : 51 - 59
  • [45] High-throughput kinase profiling as a platform for drug discovery
    Goldstein, David M.
    Gray, Nathanael S.
    Zarrinkar, Patrick P.
    NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (05) : 391 - 397
  • [46] High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma
    Kohtamaki, Laura
    Arjama, Mariliina
    Makela, Siru
    Ianevski, Philipp
    Valimaki, Katja
    Juteau, Susanna
    Ilmonen, Suvi
    Ungureanu, Daniela
    Kallioniemi, Olli
    Murumagi, Astrid
    Hernberg, Micaela
    TRANSLATIONAL ONCOLOGY, 2022, 15 (01):
  • [47] High-Throughput Functional Ex-Vivo Drug Testing and Multi-Omics Profiling in Patients with Acute Myeloid Leukemia
    Erkers, Tom
    Seashore-Ludlow, Brinton
    Struyf, Nona
    Marabita, Francesco
    James, Tojo
    Malani, Disha
    Vesterlund, Mattias
    Stalhl, Matthias
    Pawitan, Yudi
    Lehmann, Soren
    Ostling, Paivi
    Lehtio, Janne
    Kallioniemi, Olli
    BLOOD, 2019, 134
  • [48] High-throughput screen identifies a roadmap for combination drug trials
    Alessia Errico
    Nature Reviews Clinical Oncology, 2014, 11 (3) : 124 - 124
  • [49] A CLIA-CERTIFIED HIGH-THROUGHPUT DRUG SCREENING PLATFORM FOR OVARIAN CANCER TO INFORM PERSONALIZED CANCER CARE AND DISCOVER NOVEL COMBINATIONS
    Schaub, Franz X.
    Maisel, Sabrina
    Shaw, Reid
    Rosati, Rachele
    Bridgwater, Caroline
    Churchill, Michael
    Diaz, Robert
    Murphy, Stephanie Tatem
    Pereira, Shalini
    Kemp, Christopher
    Gadi, V. K.
    Grandori, Carla
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 114 - 114
  • [50] Epigenetic therapy combinations in acute myeloid leukemia: what are the options?
    Bewersdorf, Jan Philipp
    Shallis, Rory
    Stahl, Maximilian
    Zeidan, Amer M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10 : 1 - 19
12345